Oculis Announces Patient Dosing in its First Phase 3 (DIAMOND Study – DIAbetic Macular edema patients ON a Drop) with OCS-01, a Novel, Investigational Topical Eye Drop Treatment for Diabetic Macular Edema (DME)

Ads